These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32951361)

  • 61. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.
    Hostetter TH; Rennke HG; Brenner BM
    Am J Med; 1982 Mar; 72(3):375-80. PubMed ID: 7036732
    [No Abstract]   [Full Text] [Related]  

  • 62. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats.
    Miller PL; Rennke HG; Meyer TW
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F459-65. PubMed ID: 1887907
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dynamics of glomerular ultrafiltration in the rat. V. Response to ischemic injury.
    Daugharty TM; Ueki IF; Mercer PF; Brenner BM
    J Clin Invest; 1974 Jan; 53(1):105-16. PubMed ID: 4808632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diabetic glomerulopathy following unilateral nephrectomy in the rat.
    Steffes MW; Brown DM; Mauer SM
    Diabetes; 1978 Jan; 27(1):35-41. PubMed ID: 340310
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physiopathological implications of P2X
    Franco M; Bautista-Pérez R; Cano-Martínez A; Pacheco U; Santamaría J; Del Valle Mondragón L; Pérez-Méndez O; Navar LG
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F9-F19. PubMed ID: 28404593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention.
    Osterby R
    Diabetologia; 1992 Sep; 35(9):803-12. PubMed ID: 1397774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determinants of glomerular filtration in experimental glomerulonephritis in the rat.
    Maddox DA; Bennett CM; Deen WM; Glassock RJ; Knutson D; Daugharty TM; Brenner BM
    J Clin Invest; 1975 Feb; 55(2):305-18. PubMed ID: 1127101
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension.
    Dworkin LD
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):89-93. PubMed ID: 2024683
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction.
    Nath KA; Kren SM; Hostetter TH
    J Clin Invest; 1986 Nov; 78(5):1199-205. PubMed ID: 3771792
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calcium carbonate exacerbates glomerular capillary hypertension and injury in rats with desoxycorticosterone-salt hypertension.
    Dworkin LD; Feiner HD; Parker M; Randazzo J
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):444-50. PubMed ID: 2369495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit.
    Fassi A; Sangalli F; Maffi R; Colombi F; Mohamed EI; Brenner BM; Remuzzi G; Remuzzi A
    J Am Soc Nephrol; 1998 Aug; 9(8):1399-406. PubMed ID: 9697661
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
    De Nicola L; Keiser JA; Blantz RC; Gabbai FB
    Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glomerular structure and function in diabetic nephropathy. Early to advanced stages.
    Osterby R; Parving HH; Hommel E; Jørgensen HE; Løkkegaard H
    Diabetes; 1990 Sep; 39(9):1057-63. PubMed ID: 2384188
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
    Zatz R; Meyer TW; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5963-7. PubMed ID: 3862110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats.
    Oliver JD; Simons JL; Troy JL; Provoost AP; Brenner BM; Deen WM
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F917-25. PubMed ID: 7810698
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.